Multiple microbial biomolecules

Multiple microbial biomolecules" refers to the broad and diverse array of biologically active molecules produced by microorganisms, including enzymes, peptides, small metabolite compounds, and other molecular products. These molecules can play therapeutic roles as direct antimicrobials (e.g., bacteriocins, endolysins), bioactive drugs (e.g., doxorubicin, actinomycin D), modulators of host physiology and immunity (e.g., short-chain fatty acids, tryptophan derivatives), or contribute to disease mechanisms (e.g., gut microbial beta-glucuronidase in irinotecan toxicity). The group is not a single target but rather a vast and evolving collection of potential therapeutic agents and disease modifiers, each with unique biological and pharmacological properties.

Other names

microbial metabolitesmicrobial productsmicrobial natural productsmicrobial-derived moleculesbioactive microbial compounds

Enzyme inhibition (e.g., antibiotics inhibiting cell wall biosynthesis); DNA intercalation/inhibition of transcription (e.g., doxorubicin, actinomycin D); Disruption of membrane integrity (e.g., bacteriocins, some peptides); Hydrolysis of cell wall substrates (endolysins); Immunomodulation (via microbial metabolites acting as ligands for human receptors)